Therapeutic effect of an oncolytic recombinant measles virus in mouse xenograft model of refractory breast cancer cells

被引：0
|
作者：
Fujiyuki, Tomoko [1 ]
Yoneda, Misako [2 ]
Moritoh, Kanako [1 ]
Sato, Hiroki [1 ]
Kai, Chieko [1 ]
机构：
[1] Univ Tokyo, Infect Dis Contr Sci, Inst Ind Sci, Tokyo, Japan
[2] Univ Tokyo, Med Virol, Inst Ind Sci, Tokyo, Japan
来源：
CANCER SCIENCE | 2022年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
J20/21-4
引用
收藏
页码：1361 / 1361
页数：1
相关论文
共 50 条
  • [1] An oncolytic recombinant measles virus is a candidate of a novel therapeutic agent for triple negative breast cancer
    Fujiyuki, T.
    Amagai, Y.
    Shoji, K.
    Sugai, A.
    Awano, M.
    Sato, H.
    Yoneda, M.
    Kai, C.
    HUMAN GENE THERAPY, 2017, 28 (12) : A5 - A5
  • [2] Pharmacokinetics of oncolytic measles virotherapy: eventual equilibrium between virus and tumor in an ovarian cancer xenograft model
    Peng, K. -W.
    Hadac, E. M.
    Anderson, B. D.
    Myers, R.
    Harvey, M.
    Greiner, S. M.
    Soeffker, D.
    Federspiel, M. J.
    Russell, S. J.
    CANCER GENE THERAPY, 2006, 13 (08) : 732 - 738
  • [3] Pharmacokinetics of oncolytic measles virotherapy: eventual equilibrium between virus and tumor in an ovarian cancer xenograft model
    K-W Peng
    E M Hadac
    B D Anderson
    R Myers
    M Harvey
    S M Greiner
    D Soeffker
    M J Federspiel
    S J Russell
    Cancer Gene Therapy, 2006, 13 : 732 - 738
  • [4] The contribution of immune responses to the therapeutic effect of a recombinant measles virus cancer therapy
    Moritoh, Kanako
    Fujiyuki, Tomoko
    Sato, Hiroki
    Yoneda, Misako
    Kai, Chieko
    CANCER SCIENCE, 2024, 115 : 1789 - 1789
  • [5] Oncolytic activity of a recombinant SLAM-blind measles virus against scirrhous gastric cancer cells
    Fujiyuki, Tomoko
    Shoji, Koichiro
    Sugai, Akihiro
    Yamaguchi, Hideki
    Yanagihara, Kazuyoshi
    Sato, Hiroki
    Yoneda, Misako
    Kai, Chieko
    CANCER SCIENCE, 2018, 109 : 964 - 964
  • [6] Development of therapeutic biomarkers for oncolytic vaccinia virus using cell-line derived xenograft mouse model
    Ham, W. S.
    Park, J. S.
    Lee, M. E.
    Jang, W. S.
    Oh, K.
    Lee, N.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S558 - S558
  • [7] The therapeutic effect of recombinant interferon-gamma in an experimental mouse model of metastatic breast cancer
    Kumar, Shalini Sree
    Radhakrishnan, A. K.
    Chakravarthi, S.
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2011, 115 : 234P - 234P
  • [8] Oncolytic Activity of a Recombinant Measles Virus, Blind to Signaling Lymphocyte Activation Molecule, Against Colorectal Cancer Cells
    Yosuke Amagai
    Tomoko Fujiyuki
    Misako Yoneda
    Koichiro Shoji
    Yoichi Furukawa
    Hiroki Sato
    Chieko Kai
    Scientific Reports, 6
  • [9] A mouse model of persistent brain infection with recombinant Measles virus
    Schubert, S.
    Moeller-Ehrlich, K.
    Singethan, K.
    Wiese, S.
    Duprex, W. P.
    Rima, B. K.
    Niewiesk, S.
    Schneider-Schaulies, J.
    JOURNAL OF GENERAL VIROLOGY, 2006, 87 : 2011 - 2019
  • [10] Oncolytic Activity of a Recombinant Measles Virus, Blind to Signaling Lymphocyte Activation Molecule, Against Colorectal Cancer Cells
    Amagai, Yosuke
    Fujiyuki, Tomoko
    Yoneda, Misako
    Shoji, Koichiro
    Furukawa, Yoichi
    Sato, Hiroki
    Kai, Chieko
    SCIENTIFIC REPORTS, 2016, 6
12345